Sézary's disease: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 42: | Line 42: | ||
== Treatment == | == Treatment == | ||
[[Sezary's disease medical therapy|Medical Therapy]] | [[Sezary's disease surgery|Surgery]] | [[Sezary's disease primary prevention|Prevention]] | [[Sezary's disease future or investigational therapies|Future or Investigational Therapies]] | [[Sezary's disease cost-effectiveness of therapy | Cost Effectiveness of Therapy]] | [[Sezary's disease medical therapy|Medical Therapy]] | [[Sezary's disease surgery|Surgery]] | [[Sezary's disease primary prevention|Primary Prevention]] | [[Sezary's disease secondary prevention|Secondary Prevention]] | [[Sezary's disease future or investigational therapies|Future or Investigational Therapies]] | [[Sezary's disease cost-effectiveness of therapy | Cost Effectiveness of Therapy]] | ||
==Case Studies== | ==Case Studies== | ||
Revision as of 15:41, 21 September 2012
Template:DiseaseDisorder infobox Template:Sezary's disease Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: Cutaneous T-cell lymphoma; mycosis fungoides; sezary syndrome
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Sezary's Disease from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | CT | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Future or Investigational Therapies | Cost Effectiveness of Therapy
Case Studies
External links
- Illustration of Sezary cells
- http://www.clinicaltrials.gov/ct/show/NCT00106431 Clinical Trial for Sezary Syndrome